Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies
NCT05042908
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Tumor
Interventions
DRUG:
LBL-003 Injection
Sponsor
Nanjing Leads Biolabs Co.,Ltd
Collaborators
[object Object]
[object Object]
[object Object]